HomeHRTX • NASDAQ
add
Heron Therapeutics Inc
Previous close
$2.05
Day range
$2.05 - $2.14
Year range
$0.50 - $3.93
Market cap
320.78M USD
Avg Volume
1.97M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 36.02M | 13.42% |
Operating expense | 31.40M | -38.81% |
Net income | -9.24M | 78.04% |
Net profit margin | -25.64 | 80.64% |
Earnings per share | -0.06 | 82.86% |
EBITDA | -5.80M | 86.07% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 67.35M | 102.58% |
Total assets | 218.14M | 8.40% |
Total liabilities | 256.08M | 6.47% |
Total equity | -37.94M | — |
Shares outstanding | 151.67M | — |
Price to book | -8.20 | — |
Return on assets | -7.39% | — |
Return on capital | -11.26% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -9.24M | 78.04% |
Cash from operations | -4.60M | 83.05% |
Cash from investing | 2.05M | -84.51% |
Cash from financing | 492.00K | 54.23% |
Net change in cash | -2.06M | 84.85% |
Free cash flow | -4.75M | 72.66% |
About
Founded
1983
Headquarters
Website
Employees
126
